無錫振華(605319.SH):武漢全資子公司取得《項目備案證》
格隆匯1月7日丨無錫振華(605319.SH)公佈,近日,公司全資子公司武漢振華恒升祥汽車零部件有限公司(簡稱“武漢恒升祥”)取得武漢經濟技術開發區(漢南區)發展和改革局簽發的《項目備案證》(登記備案項目代碼:2501-420113-04-01-809534)。本次對外投資是公司基於長遠發展所做出的慎重決策,武漢恒升祥擬投資建設新能源汽車零部件項目的資金來源為自有或自籌資金,不會對公司財務及經營情況造成不利影響。本次投資建設將優化現有產能,提高綜合產能利用效率,降低生產成本,有利於武漢恒升祥的可持續發展,符合公司戰略發展需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.